Longboard Pharmaceuticals, Inc. (LBPH) Misses Q3 EPS by 5c

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.63), $0.05 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Trump: Pastor Darrell Scott To Serve As Tobacco Advisor
• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case